Nanobac Pharmaceuticals(NNBP)
$0.000.00 (0.00%)
NNBP
Nanobac Pharmaceuticals Statistics
$0.00
At close:0.00 (0.00%)
Nanobac Pharmaceuticals (NNBP) Stock Statistics & Valuation Metrics
6 Followers
Total Valuation
Nanobac Pharmaceuticals has a market cap or net worth of $250.00. The enterprise value is ―.
- Market Cap
- $250.00
- Enterprise Value
- ―
Share Statistics
Nanobac Pharmaceuticals has 249,507,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 249,507,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Nanobac Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -3.70M
- Employee Count
- 1
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Nanobac Pharmaceuticals had revenue of ― and earned -3.70M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 149.69K
- Operating Income
- -2.70M
- Pretax Income
- ―
- Net Income
- -3.70M
- EBITDA
- -2.52M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 21.53
- 52-Week Price Change
- ―
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Balance Sheet
Nanobac Pharmaceuticals has ― in cash and marketable securities with $5.37M in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- $5.37M
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for Nanobac Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
